ENANTA PHARMACEUTICALS INC (ENTA) Stock Institutional Trading Activity


ENANTA PHARMACEUTICALS INC (ENTA) position changes reported by tracked institutional filers across multiple SEC 13F reporting periods. Based on recent SEC 13F filings (Q4 2025), investors with some of the largest reported share count changes include Renaissance Technologies LLC. Explore insights into buying and selling patterns, position changes, and investment conviction levels to understand institutional trading behavior and market dynamics.

Explore more:

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q4 2025Renaissance Technologies LLCBuy162,600642,200$10,127,494
Q3 2025Renaissance Technologies LLCBuy10,100479,600$5,740,812
Q2 2025Renaissance Technologies LLCBuy5,900469,500$3,549,420
Q1 2025Renaissance Technologies LLCSell-34,400463,600$2,559,072
Q4 2024Renaissance Technologies LLCSell-26,900498,000$2,863,500
Q3 2024Renaissance Technologies LLCBuy14,000524,900$5,437,964
Q2 2024Renaissance Technologies LLCSell-15,200510,900$6,626,373
Q1 2024Renaissance Technologies LLCSell-32,400526,100$9,186
Q4 2023Renaissance Technologies LLCBuy100,400558,500$5,255
Q3 2023Renaissance Technologies LLCSell-18,200458,100$5,117
Q2 2023Renaissance Technologies LLCBuy48,836476,300$10,193
Q1 2023Renaissance Technologies LLCSell-45,736427,464$17,287
Q4 2022Renaissance Technologies LLCBuy5,200473,200$22,013
Q3 2022Renaissance Technologies LLCSell-74,800468,000$24,275
Q2 2022Renaissance Technologies LLCSell-64,300542,800$25,658
Q1 2022Renaissance Technologies LLCSell-107,300607,100$43,213
Q4 2021Renaissance Technologies LLCSell-42,185714,400$53,423
Q3 2021Renaissance Technologies LLCSell-41,143756,585$42,982
Q2 2021Renaissance Technologies LLCSell-102,472797,728$35,108
Q1 2021Renaissance Technologies LLCSell-133,700900,200$44,398
Q4 2020Renaissance Technologies LLCBuy4,9001,033,900$43,527
Q3 2020Renaissance Technologies LLCBuy86,1001,029,000$47,108
Q2 2020Renaissance Technologies LLCBuy62,300942,900$47,343
Q1 2020Renaissance Technologies LLCBuy149,000880,600$45,289
Q4 2019Renaissance Technologies LLCBuy68,700731,600$45,198
Q3 2019Renaissance Technologies LLCBuy112,600662,900$39,827
Q2 2019Renaissance Technologies LLCSell-95,205550,300$46,434
Q1 2019Renaissance Technologies LLCSell-151,695645,505$61,659
Q4 2018Renaissance Technologies LLCSell-51,200797,200$56,466
Q3 2018Renaissance Technologies LLCBuy3,500848,400$72,504

Frequently asked questions about ENTA activity

  • Which institutional owners are buying ENTA?

    Institutional owners buying ENTA include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in ENTA activity?

    "Buy" means an investor increased their reported position in ENTA compared to the prior reporting period. This reflects growing exposure to ENANTA PHARMACEUTICALS INC (ENTA) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in ENTA increasing?

    Institutional interest in ENTA can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.